The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials.

Arora, Charan Jeet; Rafiq, Muhammad; Shumack, Stephen; Gupta, Monisha

Arora, Charan Jeet; Rafiq, Muhammad; Shumack, Stephen; Gupta, Monisha.

Afiliación

Arora CJ; Miranda Medical Centre, Miranda, New South Wales, Australia.
Rafiq M; Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Instiutet, Stockholm, Sweden.
Shumack S; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Gupta M; Department of Dermatology, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Australas J Dermatol ; 61(1): e1-e9, 2020 Feb.

Article en En | MEDLINE | ID: mdl-31267534

Asunto(s)

Inmunosupresores/uso terapéutico; Tacrolimus/uso terapéutico; Vitíligo/terapia; Administración Tópica; Terapia Combinada; Humanos; Terapia por Láser; Fototerapia

Palabras clave

meta-analysis; systematic review; tacrolimus; vitiligo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vitíligo / Tacrolimus / Inmunosupresores Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Australas J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google